THE EMERGING PICTURE OF P53

被引:57
作者
SELTER, H
MONTENARH, M
机构
来源
INTERNATIONAL JOURNAL OF BIOCHEMISTRY | 1994年 / 26卷 / 02期
关键词
D O I
10.1016/0020-711X(94)90139-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1. The cellular phosphoprotein p53 is a negative regulator of the cell growth. A great majority of human malignancies expresses a mutated p53 that represents an oncogenic version of the protein. 2. However, in the meantime many tumors were identified containing a p53 protein without any mutation. Here also other events than genomic alterations of p53 might be implicated in the process of cell transformation. 3. The expression of wild-type or mutant conformation is not exclusively defined by the p53 DNA sequence but also influenced by the subcellular environment and the interaction of cellular proteins with p53. 4. In particular, the mdm-2 gene product appears to be an important partner of p53 somehow involved in these complex regulatory processes. 5. Recent findings supported a role for p53 in transcriptional regulation, perhaps by reducing the expression of genes that are needed for ongoing cell proliferation. 6. This property may be based upon the ability of p53 to bind DNA as well as different proteins from viral or cellular origin. 7. Especially transcription factors or further cellular proteins connected in any way with the regulation of cell proliferation are possible candidates. 8. Thus, it is not surprising that p53 is implicated in the regulation of the cell cycle and in the decision of a cell to replicate DNA or to go into apoptosis.
引用
收藏
页码:145 / 154
页数:10
相关论文
共 132 条
[1]   REGULATION OF THE HUMAN HSP70 PROMOTER BY P53 [J].
AGOFF, SN ;
HOU, J ;
LINZER, DIH ;
WU, B .
SCIENCE, 1993, 259 (5091) :84-87
[2]   ALTERATIONS IN THE P53 GENE AND THE CLONAL EVOLUTION OF THE BLAST CRISIS OF CHRONIC MYELOCYTIC-LEUKEMIA [J].
AHUJA, H ;
BARELI, M ;
ADVANI, SH ;
BENCHIMOL, S ;
CLINE, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) :6783-6787
[3]   OVERLAP OF THE P53-RESPONSIVE ELEMENT AND CAMP-RESPONSIVE ELEMENT IN THE ENHANCER OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I [J].
AOYAMA, N ;
NAGASE, T ;
SAWAZAKI, T ;
MIZUGUCHI, G ;
NAKAGOSHI, H ;
FUJISAWA, JI ;
YOSHIDA, M ;
ISHII, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5403-5407
[4]   SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[5]  
BAKER SJ, 1990, CANCER RES, V50, P7717
[6]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[7]   ENHANCED DEGRADATION OF P53 PROTEIN IN HPV-6 AND BPV-1 E6-IMMORTALIZED HUMAN MAMMARY EPITHELIAL-CELLS [J].
BAND, V ;
DALAL, S ;
DELMOLINO, L ;
ANDROPHY, EJ .
EMBO JOURNAL, 1993, 12 (05) :1847-1852
[8]   MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY [J].
BARAK, Y ;
JUVEN, T ;
HAFFNER, R ;
OREN, M .
EMBO JOURNAL, 1993, 12 (02) :461-468
[9]  
BARAK Y, 1992, EMBO J, V11, P2155
[10]   WILD-TYPE BUT NOT MUTANT P53 IMMUNOPURIFIED PROTEINS BIND TO SEQUENCES ADJACENT TO THE SV40 ORIGIN OF REPLICATION [J].
BARGONETTI, J ;
FRIEDMAN, PN ;
KERN, SE ;
VOGELSTEIN, B ;
PRIVES, C .
CELL, 1991, 65 (06) :1083-1091